Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations
JAMA Network Open · 13.05.2025 · 8 (5) · e259852
DOI: 10.1001/jamanetworkopen.2025.9852 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 13.05.2025. Verfasst von Gabrielle B Rocque und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Neoplasms, Patient Acceptance of Health Care, Symptom Assessment. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NINR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Importance Value-based health care increasingly requires electronic patient-reported outcome–based remote symptom monitoring (RSM) to improve health care utilization in patients with cancer. However, data on the impact of RSM in clinical practice are lacking.
Objective
To evaluate the association of RSM with 3- and 6-month health care utilization among patients receiving systemic cancer treatment. Design, Setting, and Participants This nonrandomized controlled trial used a hybrid, type 2 implementation-effectiveness design. Participants were patients with cancer at 2 Alabama-based academic institutions receiving chemotherapy, targeted therapy, or immunotherapy; the exposure group received standard-of-care delivered RSM from 2021 to 2024, and historical controls were patients who received cancer treatment prior to RSM implementation from 2017 to 2021. Data were analyzed from May to October 2024. Exposure RSM using electronic patient-reported outcomes. Main Outcomes and Measures Health care utilization at 3 and 6 months after RSM enrollment (intensive care unit [ICU] admissions, hospitalizations, emergency department [ED] visits). Adjusted modified Poisson models estimated the relative risk (RR) and 95% CI of health care utilization overall. Penalized logistic regression was used for stratified analyses by patient race, residence, neighborhood deprivation, insurance type, and comorbid conditions.
Results
A total of 5949 patients were assessed. From May 2021 to May 2024, 1392 patients (median [IQR] age at index date, 61 [51-69] years; 933 [67%] female) were enrolled in RSM, including 378 Black patients (27%) and 922 White patients (66%), with 262 patients (19%) living in rural areas and 372 patients (27%) living in areas with high neighborhood disadvantage; RSM patients were compared with 4557 controls (median [IQR] age at index date, 62 [53-69] years; 2654 [58%] female), including 1177 Black patients (26%) and 3151 White patients (69%), with 1012 patients (22%) living in rural areas, and 1281 patients (28%) living in areas with high neighborhood disadvantage. Compared with historical controls, hospitalizations among patients receiving RSM were 19% lower at 3 months (RR, 0.81; 95% CI, 0.73-0.91) and 13% lower at 6 months (RR, 0.87; 95% CI, 0.80-0.96). ICU admissions were not significantly different among the RSM populations compared with controls (3 months: RR, 0.82; 95% CI, 0.59-1.13; 6 months: RR, 0.83; 95% CI, 0.65-1.06). ED visits were similar for both groups (3 months: RR, 1.02; 95% CI, 0.89-1.16; 6 months: RR, 1.03; 95% CI, 0.92-1.15). Subset analyses showed similar patterns in 3- and 6-month RR for hospitalizations, ED visits, and ICU admissions. Conclusions and Relevance In this nonrandomized controlled trial, RSM implementation was associated with reduced risk of hospitalizations for patients with cancer, supporting the need to expand implementation nationally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham.
- Department of Medicine, Division of Gerontology, Geriatrics and Palliative Care, University of Alabama at Birmingham, Birmingham.
- Department of Medicine, Division of General Internal Medicine and Population Science, University of Alabama at Birmingham, Birmingham.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.
- O'Neal Comprehensive Cancer Center, Birmingham, Alabama.
- School of Nursing, University of Alabama at Birmingham, Birmingham.
Förderung
- NCATS NIH HHS
- NINR NIH HHS
- NCI NIH HHS
Zitieren
APA
Rocque, G. B., Franks, J. A., Deng, L., Caston, N. E., Williams, C. P., Azuero, A., Dent, D., Jackson, B. E., McGowan, C., Henderson, N. L., Huang, C. S., Ingram, S., Odom, J. N., Eltoum, N., Weiner, B., Howell, D., Stover, A. M., Pierce, J. Y., & Basch, E. M. (2025). Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations. JAMA Network Open, 8(5), e259852. https://doi.org/10.1001/jamanetworkopen.2025.9852
Vancouver
Rocque GB, Franks JA, Deng L, Caston NE, Williams CP, Azuero A, et al. Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations. JAMA Network Open. 2025;8(5):e259852. doi:10.1001/jamanetworkopen.2025.9852
BibTeX
@article{Rocque2025,
author = {Rocque, Gabrielle B and Franks, Jeffrey A and Deng, Luqin and Caston, Nicole E and Williams, Courtney P and Azuero, Andres and Dent, D'Ambra and Jackson, Bradford E and McGowan, Chelsea and Henderson, Nicole L and Huang, Chao-Hui Sylvia and Ingram, Stacey and Odom, J Nicholas and Eltoum, Noon and Weiner, Bryan and Howell, Doris and Stover, Angela M and Pierce, Jennifer Young and Basch, Ethan M},
title = {Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {5},
pages = {e259852},
doi = {10.1001/jamanetworkopen.2025.9852}
}
EUVIMED